The First Clinical Medical School, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
The Second Clinical Medical School, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
Front Endocrinol (Lausanne). 2022 Nov 17;13:1074516. doi: 10.3389/fendo.2022.1074516. eCollection 2022.
Acupuncture is a widely practiced, convenient, and safe treatment modality within complementary and integrative medicine. Increasing studies have revealed the efficacy of acupuncture for the treatment of osteoporosis in both human and non-human subjects. The aim of the present study was to assess the improvement of osteoporosis after overall adjustment acupuncture (OA) as well as its endocrine-modulating effect in an ovariectomized rat model.
In total, 32 female Sprague-Dawley (SD) rats were randomly divided into the sham, model, ovariectomy+estrogen (OVX+E), and OVX+OA (OVX+A) groups with eight rats in each group. The postmenopausal osteoporosis (PMOP) rat model was induced by bilateral ovariectomy. At 12 weeks after surgery, rats in the OVX+E group received estradiol (0.2 mg/kg/i.g./qod) for 12 weeks, and rats in the OVX+A group were treated with acupuncture at Zusanli (ST36), Shenshu (BL23), and Dazhu (BL11) points (qod) for 12 weeks. At the end of the treatment, all rats were sacrificed, and the body weight, uterus index, bone mineral density (BMD), bone mineral content (BMC), bone trabeculae structural parameters, femoral biomechanical properties, femoral histomorphology, and several hormone levels were examined.
In OVX rats, OA abrogated the body weight gain and improved osteoporosis in terms of BMD, BMC, bone trabeculae structural parameters, bone strength, and bone tissue histomorphology. Moreover, OA modulated the serum levels of estradiol, corticotropin releasing hormone (CRH), adrenocorticotropic hormone (ACTH), and corticosterone (CORT).
OA improves osteoporosis and exerts an endocrine-modulating effect in ovariectomized rats.
针灸是一种广泛应用的、方便的、安全的补充和整合医学治疗方式。越来越多的研究表明,针灸对人类和非人类骨质疏松症患者都具有疗效。本研究旨在评估整体调整针刺(OA)对骨质疏松症的改善作用,以及其在去卵巢大鼠模型中的内分泌调节作用。
将 32 只雌性 Sprague-Dawley(SD)大鼠随机分为假手术组、模型组、去卵巢+雌激素组(OVX+E 组)和去卵巢+OA 组(OVX+A 组),每组 8 只。通过双侧卵巢切除术建立绝经后骨质疏松症(PMOP)大鼠模型。术后 12 周,OVX+E 组大鼠给予雌二醇(0.2mg/kg/i.g./qod)治疗 12 周,OVX+A 组大鼠接受足三里(ST36)、肾俞(BL23)和大杼(BL11)穴位针刺治疗(qod)12 周。治疗结束后,处死所有大鼠,检测体重、子宫指数、骨密度(BMD)、骨矿物质含量(BMC)、骨小梁结构参数、股骨生物力学性能、股骨组织形态学和几种激素水平。
在去卵巢大鼠中,OA 可阻止体重增加,改善 BMD、BMC、骨小梁结构参数、骨强度和骨组织形态学的骨质疏松症。此外,OA 还调节了血清雌二醇、促肾上腺皮质激素释放激素(CRH)、促肾上腺皮质激素(ACTH)和皮质酮(CORT)水平。
OA 可改善去卵巢大鼠的骨质疏松症,并具有内分泌调节作用。